Insider · CIK 0001354792

Elrod James W

Reports to the SEC for 2 companies · BRISTOL, TN

sec.gov

Transactions

Companies

Filings

CIK

0001354792

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-03-03	TIVITY HEALTH, INC.A Award	VP, General Counsel	AAward	+12.5K sh	—	—	12,500
2011-03-03	TIVITY HEALTH, INC.Option to BuyA Award	VP, General Counsel	AAward	+37.5K sh	—	—	37,500
2011-01-31	KING PHARMACEUTICALS INCStock Option (Right to Buy)J Other	Chief Legal Officer, A. Sec.	JOther	−45.5K sh	—	—	0
2011-01-31	KING PHARMACEUTICALS INCD Disposition to Issuer	Chief Legal Officer, A. Sec.	DDisposition to Issuer	−41.8K sh	—	—	0
2011-01-31	KING PHARMACEUTICALS INCPerformance Share UnitsD Disposition to Issuer	Chief Legal Officer, A. Sec.	DDisposition to Issuer	−60.1K sh	—	—	0
2011-01-31	KING PHARMACEUTICALS INCPerformance Share UnitsD Disposition to Issuer	Chief Legal Officer, A. Sec.	DDisposition to Issuer	−19.3K sh	—	—	0
2011-01-31	KING PHARMACEUTICALS INCStock Option (Right to Buy)J Other	Chief Legal Officer, A. Sec.	JOther	−20K sh	—	—	0
2011-01-31	KING PHARMACEUTICALS INCStock Option (Right to Buy)J Other	Chief Legal Officer, A. Sec.	JOther	−36.9K sh	—	—	0
2011-01-31	KING PHARMACEUTICALS INCStock Option (Right to Buy)J Other	Chief Legal Officer, A. Sec.	JOther	−54.2K sh	—	—	0
2011-01-31	KING PHARMACEUTICALS INCU Disposition from Tender	Chief Legal Officer, A. Sec.	UDisposition from Tender	−166K sh	—	—	41,770
2011-01-18	KING PHARMACEUTICALS INCLong-Term Performance UnitA Award	Chief Legal Officer, A. Sec.	AAward	+19.3K sh	—	—	19,259
2011-01-07	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+17.5K sh	—	—	207,448
2011-01-07	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+17.5K sh	—	—	136,273
2010-12-31	KING PHARMACEUTICALS INCLong-Term Performance UnitM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	−40.9K sh	—	—	0
2010-12-31	KING PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	+40.9K sh	—	—	207,448
2010-11-29	KING PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer, A. Sec.	FTax Payment	−36.7K sh	$14.15	−$520K	148,968
2010-03-22	KING PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer, A. Sec.	FTax Payment	−1,735 sh	$12.25	−$21.3K	185,710
2010-03-17	KING PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Legal Officer, A. Sec.	AAward	+45.5K sh	—	—	45,540
2010-03-17	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+12.9K sh	—	—	187,445
2010-03-10	KING PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer, A. Sec.	FTax Payment	−4,029 sh	$12.22	−$49.2K	174,545
2010-02-25	KING PHARMACEUTICALS INCLong-Term Performance UnitA Award	Chief Legal Officer, A. Sec.	AAward	+60.1K sh	—	—	60,120
2009-12-31	KING PHARMACEUTICALS INCLong-Term Performance UnitM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	−13.6K sh	—	—	0
2009-12-31	KING PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	+13.6K sh	—	—	178,574
2009-03-23	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+17.2K sh	—	—	164,965
2009-03-23	KING PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Legal Officer, A. Sec.	AAward	+54.2K sh	—	—	54,230
2009-03-10	KING PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer, A. Sec.	FTax Payment	−4,404 sh	$6.31	−$27.8K	147,795
2009-02-23	KING PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer, A. Sec.	FTax Payment	−6,586 sh	$8.09	−$53.3K	152,199
2009-02-17	KING PHARMACEUTICALS INCLong-Term Performance UnitA Award	Chief Legal Officer, A. Sec.	AAward	+40.9K sh	—	—	40,940
2009-01-16	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+2,285 sh	—	—	158,785
2009-01-16	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+2,285 sh	—	—	158,785
2008-12-31	KING PHARMACEUTICALS INCLong-Term Performance UnitM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	−12.6K sh	—	—	0
2008-12-31	KING PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	+12.6K sh	—	—	156,500
2008-12-31	KING PHARMACEUTICALS INCLong-Term Performance UnitM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	−12.6K sh	—	—	0
2008-12-31	KING PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer, A. Sec.	MExercise/Conversion	+12.6K sh	—	—	156,500
2007-11-29	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+100K sh	—	—	132,200
2007-03-21	KING PHARMACEUTICALS INCA Award	Chief Legal Officer, A. Sec.	AAward	+5,860 sh	—	—	32,200
2007-03-21	KING PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Legal Officer, A. Sec.	AAward	+11.5K sh	—	—	11,520

Recent filings

Accepted (ET)
Mar 74
Elrod James W0001140361-11-014613
SEC(opens sec.gov)
Feb 24
Elrod James W0001209191-11-006504
SEC(opens sec.gov)
Jan 204/A
Elrod James W0001209191-11-004302
SEC(opens sec.gov)
Jan 204
Elrod James W0001209191-11-004307
SEC(opens sec.gov)
Jan 114
Elrod James W0001209191-11-002836
SEC(opens sec.gov)
Dec 14
Elrod James W0001209191-10-057602
SEC(opens sec.gov)
Mar 244
Elrod James W0001209191-10-018619
SEC(opens sec.gov)
Mar 194
Elrod James W0001209191-10-018041
SEC(opens sec.gov)
Mar 124
Elrod James W0001209191-10-016663
SEC(opens sec.gov)

Companies

Address

C/O KING PHARMACEUTICALS, INC. 501 FIFTH STREET

BRISTOL, TN, 37620